864947-20-6Relevant articles and documents
Second-generation highly potent and selective inhibitors of the hepatitis C virus NS3 serine protease
Chen, Kevin X.,Nair, Latha,Vibulbhan, Bancha,Yang, Weiying,Arasappan, Ashok,Bogen, Stephane L.,Venkatraman, Srikanth,Bennett, Frank,Pan, Weidong,Blackman, Melissa L.,Padilla, Angela I.,Prongay, Andrew,Cheng, Kuo-Chi,Tong, Xiao,Shih, Neng-Yang,Njoroge, F. George
scheme or table, p. 1370 - 1379 (2009/12/26)
The hepatitis C virus (HCV) infection is a leading cause of chronic liver disease. The moderate efficacy along with side effects of the current pegylated interferon and ribavirin combination therapy underscores the need for more effective and safer new tr